Table 1

Participant characteristics

Participant characteristicsControl (n=45)PEP (n=45)
Age, years67.8 (11.6)69.5 (9.8)
Gender, male:female30:1528:17
Body mass index, kg/m226.5 (6.4)24.4 (5.2)
Smoking pack years56.0 (41.3)72.3 (45.9)
FEV1, litres1.23 (0.66)0.98 (0.54)
FEV1, % predicted44.4 (20.2)37.3 (19.7)
Usual sputum producer, n (%)26 (58)28 (62)
Purulent or coloured sputum, n (%)*31 (86)34 (94)
Home oxygen, n (%)7 (16)12 (27)
Respiratory comorbidity, n (%)18 (40)18 (40)
Cardiac comorbidity, n (%)20 (44)23 (51)
AECOPD type 1, n (%)22 (49)26 (58)
AECOPD type 2, n (%)11 (24)14 (31)
AECOPD type 3, n (%)12 (27)5 (11)
pH7.40 (0.06)7.41 (0.05)
PaCO2, mm Hg48.0 (14.3)47.5 (12.5)
PaO2, mm Hg69.9 (29.8)72.2 (29.7)
Baseline BCSS7.5 (2.2)7.5 (2.0)
Baseline SGRQ total49.0 (19.5)49.9 (18.3)
Baseline SGRQ symptom68.5 (19.0)66.0 (17.9)
Baseline SGRQ activity53.0 (26.9)56.3 (27.0)
Baseline SGRQ impact40.8 (20.4)41.4 (18.3)
  • Data are mean (SD) unless otherwise stated.

  • *Percentage expressed as a proportion of samples obtained.

  • AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BCSS, Breathlessness, Cough and Sputum Scale; FEV1, forced expiratory volume in the first second; PEP, positive expiratory pressure; PaO2, partial pressure of oxygen (arterial); PaCO2, partial pressure of carbon dioxide (arterial); pH, power of hydrogen; SGRQ, St George's Respiratory Questionnaire.